Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guanqiao Li

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Seminars in Cancer Biology|September 3, 2013
Ménage à Trois in stress: DAMPs, redox and autophagyGuanqiao Li, Daolin Tang, Michael T Lotze
Frontiers in Immunology|March 23, 2013
HMGB1: The Central Cytokine for All Lymphoid CellsGuanqiao Li, Xiaoyan Liang, Michael T Lotze
Cancer Cell|October 11, 2024
Accelerated approvals: Early-phase success or premature authorization?Xiangyun Mao, G Caleb Alexander, Guanqiao Li
Brain Sciences|July 29, 2025
Health-Related Quality of Life, Psychological Health, and Patient-Reported Outcomes of Amyotrophic Lateral Sclerosis Patients in ChinaDilip Dhakal, Congzhou Chen, Bo Zhang, et al.
Medicine|April 20, 2017
Case report: A female case of isolated IgG4-related sclerosing cholangitis mimicking cholangiocarcinomaJianchun Xiao, Guanqiao Li, Gang Yang, et al.
Physical Chemistry Chemical Physics : PCCP|March 4, 2015
Complex transition metal hydrides incorporating ionic hydrogen: thermal decomposition pathway of Na2Mg2FeH8 and Na2Mg2RuH8Terry D Humphries, Motoaki Matsuo, Guanqiao Li, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
Trends and disparities in the research and development of infectious disease vaccines from 2015 to 2025Min Du, Weiyang Chen, Guanqiao Li, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2019
The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) AdministrationGuanqiao Li, Ulka Sachdev, Kevin Peters, et al.
Drug Discovery Today|October 25, 2025
Therapeutic value and regulatory characteristics of breakthrough therapy drugs in the USA and China (2021-2023): a retrospective cohort studyXiangyun Mao, Haoyu Yin, Xiaoyin Bai, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2026
Risk of bias and clinical benefit of phase III trials supporting FDA-approved anticancer medicines, 2018-2025: A cross-sectional analysisGuanqiao Li, Yiwen Pu, Congzhou Chen, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Seminars in Cancer Biology|September 3, 2013
Ménage à Trois in stress: DAMPs, redox and autophagyGuanqiao Li, Daolin Tang, Michael T Lotze
Frontiers in Immunology|March 23, 2013
HMGB1: The Central Cytokine for All Lymphoid CellsGuanqiao Li, Xiaoyan Liang, Michael T Lotze
Cancer Cell|October 11, 2024
Accelerated approvals: Early-phase success or premature authorization?Xiangyun Mao, G Caleb Alexander, Guanqiao Li
Brain Sciences|July 29, 2025
Health-Related Quality of Life, Psychological Health, and Patient-Reported Outcomes of Amyotrophic Lateral Sclerosis Patients in ChinaDilip Dhakal, Congzhou Chen, Bo Zhang, et al.
Medicine|April 20, 2017
Case report: A female case of isolated IgG4-related sclerosing cholangitis mimicking cholangiocarcinomaJianchun Xiao, Guanqiao Li, Gang Yang, et al.
Physical Chemistry Chemical Physics : PCCP|March 4, 2015
Complex transition metal hydrides incorporating ionic hydrogen: thermal decomposition pathway of Na2Mg2FeH8 and Na2Mg2RuH8Terry D Humphries, Motoaki Matsuo, Guanqiao Li, et al.
Human Vaccines & Immunotherapeutics|November 6, 2025
Trends and disparities in the research and development of infectious disease vaccines from 2015 to 2025Min Du, Weiyang Chen, Guanqiao Li, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2019
The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) AdministrationGuanqiao Li, Ulka Sachdev, Kevin Peters, et al.
Drug Discovery Today|October 25, 2025
Therapeutic value and regulatory characteristics of breakthrough therapy drugs in the USA and China (2021-2023): a retrospective cohort studyXiangyun Mao, Haoyu Yin, Xiaoyin Bai, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2026
Risk of bias and clinical benefit of phase III trials supporting FDA-approved anticancer medicines, 2018-2025: A cross-sectional analysisGuanqiao Li, Yiwen Pu, Congzhou Chen, et al.
Pageof 6